Revolution Medicines, Inc.
RVMD
$149.94
$4.222.90%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -9.25% | -11.52% | 24.66% | 34.35% | 23.43% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 87.51% | 28.76% | 55.04% | 15.44% | 24.34% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -7.81% | -10.85% | 25.23% | 33.96% | 23.44% |
|
|
|||||
| Total Current Assets | -7.81% | -10.85% | 25.23% | 33.96% | 23.44% |
| Net Property, Plant & Equipment | 12.90% | 16.54% | 68.81% | 46.19% | 43.09% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -1.07% | -1.54% | -1.88% | -1.87% | -1.86% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 221.13% | 149.23% | 177.88% | 212.57% | 134.08% |
| Total Assets | -4.72% | -7.97% | 27.73% | 34.35% | 23.95% |
|
|
|||||
| Total Accounts Payable | 69.53% | 18.72% | 206.06% | 93.60% | 46.72% |
| Total Accrued Expenses | 94.12% | 109.81% | 90.54% | 70.42% | 85.89% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 27.98% | 27.94% | 94.45% | 57.08% | 58.88% |
| Total Finance Division Other Current Liabilities | 400.92% | 1,247.86% | 544.84% | -29.68% | -12.50% |
| Total Other Current Liabilities | 400.92% | 1,247.86% | 544.84% | -29.68% | -12.50% |
| Total Current Liabilities | 82.60% | 77.18% | 121.55% | 75.19% | 69.22% |
|
|
|||||
| Total Current Liabilities | 82.60% | 77.18% | 121.55% | 75.19% | 69.22% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 15.37% | 15.66% | 81.50% | 51.37% | 51.97% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 501.56% | 255.88% | 42.91% | 187.47% | -22.24% |
| Total Liabilities | 162.47% | 146.75% | 233.01% | 197.59% | 57.03% |
|
|
|||||
| Common Stock & APIC | 19.76% | 12.38% | 31.95% | 35.09% | 35.14% |
| Retained Earnings | -70.30% | -65.10% | -62.27% | -58.55% | -55.64% |
| Treasury Stock & Other | -136.44% | 145.04% | -18.26% | 169.89% | 242.49% |
| Total Common Equity | -27.82% | -27.98% | 1.95% | 15.23% | 20.44% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -27.82% | -27.98% | 1.95% | 15.23% | 20.44% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -27.82% | -27.98% | 1.95% | 15.23% | 20.44% |
|
|
|||||